lenalidomide

lenalidomide

美 　英

• 網絡來那度胺；來拉度胺；沙利度胺類似物

例句

This paper summarizes the mechanism, pharmacokinetics, clinical application, adverse reactions and drug interactions of lenalidomide.

現對其作用機制、藥動學、臨床應用、不良反應、藥物相互作用等做一綜述。

Lenalidomide has activity in a variety of hematologic malignancies, including non-Hodgkin's lymphoma (NHL).

來那度胺對包括非霍奇金淋巴瘤（NHL）在內的許多血液系統惡性腫瘤均有治療作用。

CONCLUSION: Oral lenalidomide monotherapy is active in relapsed or refractory aggressive NHL, with manageable side effects.

結論：口服來那度胺單一療法對復發性或難治性侵襲性NHL有效，且藥物副作用容易控制。

Lenalidomide is not technically a chemotherapy drug, is given orally and in certain situations can by very effective.

來那度胺，技術上來講并非一種化療藥物，可以口服并且某些情況下非常見效。

Objective: To optimize the synthetic route of lenalidomide.

目的：優化來那度胺的合成路線。

A new immunomodulatory drug lenalidomide: pharmacological activity and clinical research

新型免疫調節藥來那度胺的藥理及臨床研究進展